Log In
Print
BCIQ
Print
Print this Print this
 

DSP-2230

  Manage Alerts
Collapse Summary General Information
Company Sumitomo Dainippon Pharma Co. Ltd.
DescriptionInhibitor of voltage-gated sodium channels Nav1.7 and Nav1.8
Molecular Target Nav1.7 (SCN9A) ; Nav1.8 (PN3) (SCN10A)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat neuropathic pain
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today